Position Statement of the Max Planck Institute for Innovation and Competition of 25 May 2022 on the Commission's Proposal of 23 February 2022 for a Regulation on Harmonised Rules on Fair Access to and Use of Data (Data Act)
Josef Drexl(Max Planck Institute for Innovation and Competition), Klaus Wiedemann(Universität Hamburg), Valentina Moscon(Max Planck Institute for Innovation and Competition), Shraddha Kulhari(Max Planck Institute for Innovation and Competition), Daria Kim(Max Planck Institute for Innovation and Competition), Carolina Banda(Max Planck Institute for Innovation and Competition), Heiko Richter(Max Planck Institute for Innovation and Competition), Jörg Hoffmann(Max Planck Institute for Innovation and Competition), Begoña González Otero(Max Planck Institute for Innovation and Competition)
Cited by 23
Related Papers
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
|Blood|2007|356
Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
|PLoS Genetics|2007|325
Factor H and Atypical Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2005|123
The Data Sharing Economy: On the Emergence of New Intermediaries
|GRURRR. Gewerblicher Rechtsschutz und Urheberrecht, Rechtsprechungs-Report/GRUR-DVD/GRUR-CD/IIC/Gewerblicher Rechtsschutz und Urheberrecht/Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil|2018|101
Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome
|Nephrology Dialysis Transplantation|2009|78